Spectral Medical (SD4) Stock Statistics & Valuation Metrics

Spectral Medical has a market cap or net worth of €248.13M. The enterprise value is €437.01M.

Spectral Medical has 293,418,980 shares outstanding. The number of shares has decreased by -2.65% in one year.

Spectral Medical’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 26.80%.

The current PE Ratio of Spectral Medical is ―. Spectral Medical’s PEG ratio is -0.04.

In the last 12 months, Spectral Medical had revenue of 2.44M and earned -47.69M in profits. Earnings per share was -0.17.

In the last 12 months, operating cash flow was -11.11M and capital expenditures -28.00K, giving a free cash flow of -11.14M billion.

Spectral Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Spectral Medical upcoming earnings date is Aug 7, 2026, TBA (Confirmed).

Spectral Medical as a current ratio of 0.08, with Debt / Equity ratio of -31.47%

In the past 12 months, Spectral Medical has paid 0.00 in taxes.

Spectral Medical EV to EBITDA ratio is -37.66, with an EV/FCF ratio of -44.30.

Spectral Medical has €1.92M in cash and marketable securities with €22.27M in debt, giving a net cash position of -€20.35M billion.

Gross margin is -79.25%, with operating margin of -478.50%, and net profit margin of -1952.99%.

The average price target for Spectral Medical is €2.18, which is 11.43% higher than the current price. The consensus rating is Moderate Buy